West Pharmaceutical Services (BSP:W2ST34) Long-Term Debt : R$363 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Long-Term Debt?

West Pharmaceutical Services's Long-Term Debt for the quarter that ended in Mar. 2024 was R$363 Mil.

West Pharmaceutical Services's quarterly Long-Term Debt declined from Sep. 2023 (R$751 Mil) to Dec. 2023 (R$357 Mil) but then increased from Dec. 2023 (R$357 Mil) to Mar. 2024 (R$363 Mil).

West Pharmaceutical Services's annual Long-Term Debt declined from Dec. 2021 (R$1,181 Mil) to Dec. 2022 (R$1,084 Mil) and declined from Dec. 2022 (R$1,084 Mil) to Dec. 2023 (R$357 Mil).

West Pharmaceutical Services Long-Term Debt Historical Data

The historical data trend for West Pharmaceutical Services's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Long-Term Debt Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

1,046.65

1,301.10

1,180.74

1,084.22

356.71

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															1,073.49	997.92	751.18	356.71	362.53

West Pharmaceutical Services (BSP:W2ST34) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

West Pharmaceutical Services Long-Term Debt Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (BSP:W2ST34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (BSP:W2ST34) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services (BSP:W2ST34) Headlines

No Headlines